90/015,927EPINEPHRINE COMPOSITIONS AND CONTAINERS12,533,328Open

Status

Response after Non-Final Action Entered (or Ready for Examiner Action)

Filed

Jan 30, 2026

Last Updated

Aug 14, 2026

Art Unit

3991

Requested By

Third Party

Patent Owner

Nevakar Inc.

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

514Drug, Bio-Affecting And Body Treating Compositions

Reexam History (31 events)

Aug 14, 2026RXC/SRCertificate of Service
Aug 14, 2026RXA...Response after Non-Final Action
Jul 13, 2026RXC/SRCertificate of Service
Jun 16, 2026MR.NFRX - Mail Reexam Non-Final Action
Jun 4, 2026IDSCInformation Disclosure Statement considered
May 28, 2026IDSCInformation Disclosure Statement considered
May 28, 2026IDSCInformation Disclosure Statement considered
May 28, 2026IDSCInformation Disclosure Statement considered
May 5, 2026RXFWDXDate Forwarded to Examiner
May 1, 2026WIDSInformation Disclosure Statement (IDS) Filed
May 1, 2026WIDSInformation Disclosure Statement (IDS) Filed
May 1, 2026WIDSInformation Disclosure Statement (IDS) Filed
May 1, 2026RXIDS.Information Disclosure Statement Filed
Mar 4, 2026MREXORX - Mail Ex Parte Request for Reexamination Granted
Feb 13, 2026MRXNReexamination Formalities Notice Mailed
Feb 13, 2026MRXNReexamination Formalities Notice Mailed
Feb 13, 2026DOCKCase Docketed to Examiner in GAU
Feb 13, 2026COMPApplication Is Now Complete
Feb 12, 2026RXTTLRPTTitle Report
Feb 12, 2026RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Feb 12, 2026RXNREQFDNotice of reexamination request filing date
Feb 12, 2026RXNREQAUNotice of assignment of reexamination request
Feb 2, 2026RXLITSRReexam Litigation Search Conducted
Feb 2, 2026PRXRParalegal Reexam Review Complete
Feb 2, 2026FTFSFITF set to YES - revise initial setting
Jan 30, 2026WIDSInformation Disclosure Statement (IDS) Filed
Jan 30, 2026RXOSUB.RReexamination requested by third party requester
Jan 30, 2026RXOSUBReceipt of Original Ex Parte Reexam Request
Jan 30, 2026RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Jan 30, 2026RXAF/DRReexam - Affidavit(s), Declaration(s) and/or Exhibit(s) Filed by Third Party Requester
Jan 30, 2026BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedApr 7, 2025

Prosecution History

DateCodeDescription
Apr 8, 2025P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Apr 8, 2025P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Apr 7, 2025DISTTerminal Disclaimer Filed
Apr 7, 2025DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
Jan 27, 2026
3.5-yr
Jul 27, 2029
7.5-yr
Jul 27, 2033
11.5-yr
Jul 27, 2037
Expiry
Dec 23, 2044

Entity Status

Large Entity

Expires

Dec 23, 2044 (18.7 yr remaining)

Assignments

20182019202020212022202320242025FiledPREM SAGAR AKASAPUIOURI V. ILITCHEVMILAN PATELREEMA AJITKUMAR PURIKUMARESH SOPPIMATHPOOJA H. TENDULKARNEVAKAR, LLCNEVAKAR, INC.NEVAKAR, LLCNEVAKAR INJECTABLES INC.
Name ChangeReel/Frame: 069764/0798Recorded: Dec 23, 2024

From

NEVAKAR, LLC
Jan 23, 2018

To

NEVAKAR, INC.

AssignmentReel/Frame: 069670/0497Recorded: Dec 23, 2024

From

PREM SAGAR AKASAPUInventor
Mar 26, 2018
IOURI V. ILITCHEVInventor
Mar 26, 2018
MILAN PATELInventor
Mar 26, 2018
REEMA AJITKUMAR PURIInventor
Mar 26, 2018
KUMARESH SOPPIMATHInventor
Mar 26, 2018
POOJA H. TENDULKARInventor
Mar 26, 2018

To

NEVAKAR, LLC

AssignmentReel/Frame: 069670/0604Recorded: Dec 23, 2024

From

NEVAKAR INC.
Jul 30, 2021

To

NEVAKAR INJECTABLES INC.